Heart attack is a medical condition of sudden interruption or insufficiency of the supply of blood to the heart, typically resulting from occlusion or obstruction of a coronary artery and often characterized by severe chest pain. Also called myocardial infarction.
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved Praluent® (alirocumab) Injection, the first FDA-approved treatment in a new
FDA approves new antiplatelet drug used during heart procedure – The U.S. Food and Drug Administration approved Kengreal (cangrelor), an intravenous antiplatelet drug that prevents formation of harmful blood clots in the coronary arteries, the blood vessels that supply blood to the heart.
New drug alirocumab halved number of heart attacks and strokes – An experimental cholesterol-lowering drug from Sanofi and Regeneron Pharmaceuticals roughly halved the number of heart attacks and strokes in a clinical trial, revealed by researchers at the European Society of Cardiology yearly gathering in Barcelona.
Baby hearts need rhythm to develop correctly – To develop correctly, baby hearts need rhythm even before they have blood to pump. “We have discovered that mechanical forces are important when making baby hearts,” said Mary Kathryn Sewell-Loftin, a Vanderbilt graduate student working with a team of Vanderbilt engineers, scientists and clinicians attempting to grow replacement heart valves from a patient’s own cells.
Here comes the sun to lower your blood pressure – Exposing skin to sunlight may help to reduce blood pressure and thus cut the risk of heart attack and stroke, a study published in the Journal of Investigative Dermatology suggests. Research carried out at the Universities of Southampton and Edinburgh shows that sunlight alters levels of the small messenger molecule, nitric oxide (NO) in the skin and blood, reducing blood pressure.
Findings Not Supportive of Women-Specific Chest Pain Symptoms in Heart Attack Diagnosis – Using chest pain characteristics (CPCs) specific to women in the early diagnosis of acute myocardial infarction (AMI, heart attack) in the emergency department does not seem to be supported by the findings of a study published by JAMA.
High salt levels in common medicines put patients at increased risk of cardiovascular events — Researchers call for salt content of medicines to be labeled in same way as foods – Taking the maximum daily dose of some medicines would exceed the recommended daily limits for sodium, without any additional dietary intake. Public should be warned about the potential dangers of high sodium intake from prescribed medicines, reveals new study.
Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation — New findings showing mitral valve replacement may be more effective than mitral valve repair reported at AHA Scientific Sessions 2013 and in New England Journal of Medicine – The Cardiothoracic Surgical Trials Network (CTSN), whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation — mitral valve repair and mitral valve replacement.
Study confirms link between omega-3 fatty acids and increased prostate cancer risk — Consumption of fatty fish and fish-oil supplements linked to 71 percent higher risk – A second large, prospective study by scientists at Fred Hutchinson Cancer Research Center has confirmed the link between high blood concentrations of omega-3 fatty acids and an increased risk of prostate cancer.
Sunshine could benefit health and prolong life, study suggests – Exposing skin to sunlight may help to reduce blood pressure, cut the risk of heart attack and stroke – and even prolong life. Researchers have shown that when our skin is exposed to the sun’s rays, a compound is released in our blood vessels that helps lower blood pressure.
